EcoDrugPlus

Ribosomal Protein S26

Ensembl ID : ENSMMDG00005021376
Gene Symbol: RPS26
3 Cross references
375 Possible Orthologues:

Ribosomal Protein S28

Ensembl ID : ENSMMDG00005011466
Gene Symbol: RPS28
3 Cross references
274 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSMMDG00005003489
Gene Symbol: RPS3A
3 Cross references
360 Possible Orthologues:

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSMMDG00005011866
Gene Symbol: RPS4X
3 Cross references
494 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSMMDG00005005866
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S6 Kinase B1

Ensembl ID : ENSMMDG00005010924
Gene Symbol: RPS6KB1
3 Cross references
155 Possible Orthologues:

Ribosomal Protein S6 Kinase B1

Ensembl ID : ENSMMDG00005013554
Gene Symbol: RPS6KB1
3 Cross references
78 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSMMDG00005010678
Gene Symbol: RPS7
3 Cross references
349 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSMMDG00005023497
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSMMDG00005009842
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSMMDG00005009540
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSMMDG00005003107
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).